Background Recent studies suggest that the risk factor profile of patients presenting with ST elevation myocardial infarction (STEMI) is changing. Aim The aim is to determine if there has been a shift of cardiovascular risk factors to cardiometabolic causes in the first presentation STEMI population. Method We analysed data from a STEMI registry from a large tertiary referral percutaneous coronary intervention centre to determine the prevalence and trends of the modifiable risk factors of hypertension, diabetes, smoking and hypercholesterolaemia. Participants Consecutive first presentation STEMI patients between January 2006 to December 2018. Results Among the 2,366 patients included (mean age 59, SD 12.66, 80% male) the common risk factors were hypertension (47%), hypercholesterolaemia (47%) current smoking (42%) and diabetes (27%). Over the 13 years, patients with diabetes (20% to 26%, OR 1.09 per year, CI 1.06-1.11, p<0.001) and patients with no modifiable risk factors increased (9% to 17%, OR 1.08, CI 1.04-1.11, p<0.001). Concurrently there was a fall in prevalence of hypercholesterolaemia, (47% to 37%, OR 0.94 per year, CI 0.92-0.96, p<0.001) and smoking (44% to 41%, OR 0.94, CI 0.92-0.96, p<0.001) but no significant change in rates of hypertension (53% to 49%, OR 0.99, CI 0.97-1.01, p=0.25). Conclusion The risk factor profile of first presentation STEMI has changed over time with a reduction in smoking and a concurrent rise in patients with no traditional risk factors. This suggests the mechanism of STEMI may be changing and further investigation of potential causal factors is warranted for the prevention and man-agement of cardiovascular disease.

BACKGROUND:Thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI) was recommended to minimize distal embolization and to reduce thrombus burden prior to PPCI. Subsequent randomized trials showed no mortality benefit from TA and suggested an increased risk of stroke up to 180 days following TA, although it was not obvious that the procedure alone caused the strokes. METHODS AND RESULTS:This study retrospectively analyzed the periprocedural stroke rate in a series of STEMI patients treated with TA and PPCI at a single, large, tertiary hospital, where a rigorous uniform protocol of aspiration was used in all patients. Of 3734 patients, 1404 patients (38%; group 1) underwent TA as part of the PPCI procedure and 2330 patients (62%; group 2) did not undergo TA. There were no significant clinical differences between the 2 groups. In total, there were 20 strokes (0.54%), with 3 (0.2%) occurring in group 1, and 17 (0.7%) occurring in group 2 (P=.04). The majority of strokes occurred within 5 days of the procedure, and 3 (0.08%) were hemorrhagic. There were 22 intraprocedural deaths (0.6%), related to cardiogenic shock. There were no intraprocedural strokes. CONCLUSIONS:Very low stroke rates immediately post STEMI were seen in patients undergoing TA and PPCI in this real-world study. TA can be performed safely in STEMI patients undergoing PPCI with a short-term stroke risk equivalent to risk without TA. Further studies may be needed to explain the increased incidence of late stroke noted after TA and elucidate causative mechanisms.

Chronic total occlusion (CTO) of a major epicardial coronary artery is a common finding, reported in some series as occurring in up to 20% of patients with coronary disease undergoing coronary angiography [ [1] Fefer P. Knudtson M.L. Cheema A.N. Galbraith P.D. Osherov A.B. Yalonetsky S. et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012; 59: 991-997 Crossref PubMed Scopus (466) Google Scholar ]. With rates potentially being this high, it is disappointing that it remains unknown whether CTOs have similar benefit from percutaneous coronary intervention (PCI) to non-CTO coronary lesions. This is largely because CTO patients were previously excluded from most revascularisation trials [ [2] Strauss B.H. Shuvy M. Wijeysundera H.C. Revascularization of chronic total occlusions. J Am Coll Cardiol. 2014; 64: 1281-1289 Crossref PubMed Scopus (36) Google Scholar ]. Historically, it would have been common not to consider PCI [ [3] Hochman J.S. Lamas G.A. Buller C.E. Dzavik V. Reynolds H.R. Abramsky S.J. et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355: 2395-2407 Crossref PubMed Scopus (550) Google Scholar ] and this would have been justified by the limited evidence-based data available, low success rate, lack of well-defined approach and prolonged procedure time. However, the clinical landscape has now changed. With new interventional advances, especially with guidewires, microcatheters and new techniques, there has been an ever increasing interest in attempting to open chronically occluded epicardial coronary arteries and this has been accompanied by increased procedural success rates [ 4 Tajti P. Burke M.N. Karmpaliotis D. Alaswad K. Werner G.S. Azzalini L. et al. Update in the percutaneous management of coronary chronic total occlusions. JACC Cardiovasc Interv. 2018; 11: 615-625 Crossref PubMed Scopus (56) Google Scholar , 5 Patel V.G. Brayton K.M. Tamayo A. Mogabgab O. Michael T.T. Lo N. et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions. JACC Cardiovasc Interv. 2013; 6: 128-136 Crossref PubMed Scopus (0) Google Scholar ]. Indications for Percutaneous Coronary Intervention (PCI) in Chronic Total Occlusion (CTO): Have We Reached a DECISION or Do We Continue to EXPLORE After EURO-CTO?Heart, Lung and CirculationVol. 28Issue 10PreviewA coronary chronic total occlusion (CTO) is a common finding during coronary angiography and is associated with increased mortality and poorer cardiovascular prognosis. Technological developments in percutaneous strategies for revascularisation have resulted in increased interest in this area. However, until recently, there has been a paucity of robust scientific randomised data comparing the efficacy of medical management with percutaneous strategies. Both observational data, and to a lesser extent, randomised data, suggest that CTO percutaneous coronary intervention (PCI) should be considered in symptomatic patients. Full-Text PDF Chronic Total Occlusion Wiring: A State-of-the-Art Guide From The Asia Pacific Chronic Total Occlusion ClubHeart, Lung and CirculationVol. 28Issue 10PreviewDespite the advances in wire technology and development of algorithm-driven methodology for chronic total occlusion (CTO) intervention, there is a void in the literature about the technical aspects of CTO wiring. The Asia Pacific CTO Club, a group of 10 experienced operators in the Asia Pacific region, has tried to fill this void with this state-of-the-art review on CTO wiring. Full-Text PDF Open AccessRadiation Management in Coronary Angiography: Percutaneous Coronary Intervention for Chronic Total Occlusion at the FrontierHeart, Lung and CirculationVol. 28Issue 10PreviewThe usage of ionising radiation in medical investigations and procedures continues to increase. Cardiologists are responsible for a disproportionately high amount of this radiation, and the performance of percutaneous coronary intervention for chronic total occlusions (CTO PCI) often requires particularly high radiation doses. Consequently, both patients and proceduralists are potentially being exposed to harmful doses of radiation. This review discusses the potential dangers of radiation exposure during CTO PCI, as well as techniques to minimise radiation dose to the patient and proceduralist. Full-Text PDF

Introduction: Many patients deemed inoperable for surgical aortic valve replacement (SAVR) have been treated successfully by transcatheter aortic-valve replacement (TAVR). This meta-analysis is designed to evaluate the performance of TAVR in comparison with SAVR.Methods: A systematic search was conducted using MEDLINE, PubMed, EMBASE, Current Contents Connect, the Cochrane library, Google Scholar, Science Direct and Web of Science. Original data were abstracted from each study and used to calculate a pooled OR and 95% CI.Results: Among three randomised controlled trials (RCTs), differences between the two cohorts were not statistically significant for the frequency of stroke (OR=1.94, 95% CI=0.813 to 4.633), incidence of myocardial infarction (MI), (OR=0.765, 95% CI=0.05 to 11.76) 30-day mortality rate, 1-year mortality rate (0.82, 95% CI=0.62 to 1.09) and acute kidney injury incidence rate. The non-RCTs demonstrated that the TAVR group had an amplified frequency aortic regurgitation at discharge (OR=5.465, 95% CI=3.441 to 8.680). While differences between the two cohorts were not statistically significant for the incidence of MI (OR=0.697, 95% CI=0.22 to 2.21), stroke (OR=0.575, 95% CI=0.263 to 1.259), acute renal failure requiring haemodialysis (OR=0.943, 95% CI=0.276 to 3.222), 30-day mortality (OR=0.869, 95% CI=0.621 to 1.216) and the need for a pacemaker (OR=1.832, 95% CI=0.869 to 3.862), a lower incidence of patients needing transfusion (OR=0.349, 95% CI=0.121 to 1.005) and new-onset atrial fibrillation (OR=0.296, 95% CI=0.124 to 0.706) was seen in the TAVR group.Conclusions: Randomised and observational evidence adjusted on the baseline patient's characteristics finds a similar risk for 30 days mortality, 1-year mortality, stroke, MI and acute kidney injury in TAVR and SAVR.

Defibrillation is often required to terminate a ventricular fibrillation or fast ventricular tachycardia rhythm and resume a perfusing rhythm in sudden cardiac arrest patients. Automated external defibrillators rely on automatic ECG analysis algorithms to detect the presence of shockable rhythms before advising the rescuer to deliver a shock. For a reliable rhythm analysis, chest compression must be interrupted to prevent corruption of the ECG waveform due to the artifact induced by the mechanical activity of compressions. However, these hands-off intervals adversely affect the success of treatment. To minimize the hands-off intervals and increase the chance of successful resuscitation, we developed a method which asks for interrupting the compressions only if the underlying ECG rhythm cannot be accurately determined during chest compressions. Using this method only a small percentage of cases need compressions interruption, hence a significant reduction in hands-off time is achieved. Our algorithm comprises a novel filtering technique for the ECG and thoracic impedance waveforms, and an innovative method to combine analysis from both filtered and unfiltered data. Requiring compression interruption for only 14% of cases, our algorithm achieved a sensitivity of 92% and specificity of 99%.

AIMS:We sought to explore whether global and regional scientific output in cardiovascular medicine is associated with economic variables and follows the same trend as medicine and as science overall.METHODS AND RESULTS:We registered the number of documents, number of citations, citations per document and the h-index for the first 50 countries according to the h-index (a measure to evaluate both the productivity and impact of the publications) in cardiovascular medicine. Economic variables (gross domestic product [GDP] per capita, % expenditure of the GDP in research and development [R&D] and health) were obtained from the World Bank, the UNESCO, and the World Health Organization. In total, the scientific output in cardiology showed the same position as in medicine and science overall (mean difference vs. medicine -0.9±5.3º, p=0.25 vs. science -0.7±5.3º, p=0.39). We found significant correlations between the h-index and the % GDP expenditure in R&D (r=0.67, p<0.001), and the % GDP expenditure in health (r=0.71, p<0.0001). Overall, there was a 21.4% (interquartile range 3.7; 55.0) increase in the % GDP expenditure in R&D between 1996 and 2007. Emerging economies showed the larger growth in % GDP expenditure in health and R&D.CONCLUSIONS:The global situation of scientific output in cardiovascular medicine is highly polarised and closely related to economic indicators. Emergent economies, with higher rates of GDP growth and increasingly larger expenditures for R&D and healthcare, are expected to show a visible escalation in the scientific global picture in the near future.

BACKGROUND Prompt thrombolytic reperfusion reduces postinfarct ventricular electrical instability after ST elevation myocardial infarction (STEMI).OBJECTIVE The purpose of this study was to examine the relationship between reperfusion time and inducible ventricular tachycardia (VT) early and spontaneous ventricular arrhythmias (VAs) late after primary percutaneous coronary intervention (PCI) for STEMI.METHODS Consecutive patients were recruited if they (1) had no prior coronary disease, (2) had been reperfused with primary PCI, (3) had postinfarct ejection fraction <= 40%, and (4) had undergone cardiac electrophysiologic study (n = 128). Three groups were compared according to reperfusion time: early (< 3 hours, n = 26), intermediate (> 3-5 hours, n = 45), or delayed reperfusion (> 5 hours, n = 57). Spontaneous VA was a composite endpoint of sudden death or defibrillator-treated VA.RESULTS Mean ejection fraction (33% +/- 5%, 31% +/- 6%, and 31% +/- 7%, P = .41) and peak creatinine kinase (P = .37) were similar between groups. VT was inducible in 11.5%, 17.8%, and 36.8% of patients in the early, intermediate, and delayed reperfusion groups, respectively (P = .003). At 2 years, the incidence of spontaneous VA was 0%, 8.9%, and 14% in the early, intermediate, and delayed reperfusion groups, respectively (P = .025). By multivariable analysis, delayed reperfusion conferred a sixfold increase in the odds of inducible VT (P = .01). Although inducible VT was the strongest predictor of spontaneous VA (hazard ratio 14.31, P = .001), delayed reperfusion conferred a threefold increase in risk when inducible VT was excluded from the multivariable model (P = .035).CONCLUSION Reperfusion time is a critical determinant of postinfarct ventricular electrical instability early and late after STEMI treated with primary PCI.

ST segment resolution (STR) predicts epicardial and microvascular reperfusion after primary percutaneous coronary intervention (PPCI) or thrombolysis for ST-elevation myocardial infarction. Immediate restoration of epicardial coronary flow, with improved microvascular perfusion, is much more likely with PPCI. However, the predictive value of immediate STR compared to 90 minutes after PPCI remains unknown. In 622 consecutive patients with ST-elevation myocardial infarction (mean age 59 +/- 13 years), 217 had complete STR immediately after PPCI (group A), 188 had complete STR only at 90 minutes (group B), and 217 had incomplete STR at either point (group C). The primary end point was mortality and adverse cardiovascular events ([MACE] death, nonfatal repeat myocardial infarction, and heart failure). Group A had a greater left ventricular ejection fraction (53%, 47%, and 46%, p <0.001) and lower all-cause mortality (1.8%, 3.2%, and 6%, p = 0.07), lower heart failure (1.8%, 4.3%, and 7.8%, p <0.001), and MACE (5.1%, 9.6%, and 16.1%, p = 0.001) at 30 days compared to groups B and C, respectively. The rate of MACE at 1 year was 7.6%, 17.1%, and 20.2% in groups A, B, and C, respectively (p <0.001). Immediate STR independently predicted MACE (adjusted hazard ratio 0.36, 95% confidence interval 0.21 to 0.61, p = 0.001, group A vs C), and STR at 90 minutes did not. In conclusion, STR analysis performed immediately after PPCI provided superior differentiation for adverse cardiovascular events compared to STR at 90 minutes. Immediate STR should be the contemporary goal of reperfusion with PPCI. (C) 2010 Published by Elsevier Inc. (Am J Cardiol 2010;105:467-474)

Q waves can develop early in infarction and indicate infarct progression better than symptom duration. ST resolution (STR) is a predictor of reperfusion success. Our aim was to assess the prognostic impact of Q waves on presentation and STR after primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction. The combined end point was of mortality and adverse cardiovascular events (MACE; death, repeat myocardial infarction, or heart failure). Q waves on presentation (Q wave, n = 332; no Q wave, n = 337) was associated with significantly less mean STR, greater incidence of akinetic, dyskinetic, or aneurysmal regional wall motion, lower left ventricular ejection fraction, and worse in-hospital and 1-year MACEs (1 year 24% vs 8.2%, p <0.001). In addition, Q waves on presentation compared to no Q waves were associated with worse I-year MACE regardless of infarct presentation in <= 3 hours, infarct location, and adequate STR (70%). Q waves on presentation and inadequate STR (<70%), but not symptom duration, were independent predictors of MACE by multivariable analysis (adjusted hazard ratios of 2.7 and 2.4 for Q waves and STR, respectively). Compared to group A (no Q waves on presentation with STR), patients in group B (no Q waves with inadequate STR), group C (Q waves with STR), and group D (Q waves with inadequate STR) had hazard ratios of 3.0, 3.6, and 7.7, respectively (p <0.05) for the occurrence of MACE. In conclusion, assessment of Q-wave status on presentation and STR immediately after PPCI provides a simple and early clinical predictor of outcomes in ST-elevation myocardial infarction. (C) 2009 Elsevier Inc. All rights reserved. (Am J Cardiol 2009;104:780-785)

Shorter reperfusion times lead to better outcomes in patients with ST-elevation myocardial infarction (STEMI). We assessed the efficacy of prehospital triage with bypass of community hospitals and early activation of the cardiac catheterization team on revascularization times, left ventricular (LV) ejection fraction, and survival. Patients with STEMI (624) were divided into 3 groups determined by site of triage: ambulance field triage (163), interventional center emergency department (202), and 3 community hospital emergency departments (259). Compared with community hospital and interventional center triages, ambulance field triage resulted in a significant median decrease in door-to-balloon times of 68 and 27 minutes, respectively (p <0.00i). LV ejection fraction was highest in the field triage group (52 +/- 13%) compared with the interventional center (49 +/- 12%) and community hospital (48 +/- 12%, p = 0.017) groups. Thirty-day mortality was lowest in the ambulance field group (3%) compared with the interventional facility (11%) and community hospital (4%, p = 0.007) groups. There was a significant difference in long-term survival with up to 30-month follow-up among the 3 triage groups (p = 0.041). With time-dependent Cox regression modeling the difference in survival was significant only during the first week after STEM]. (p = 0.020). Every extra minute of symptom onset to reperfusion time was associated with a relative risk of long-term mortality of 1.003 (95% confidence interval 1.000 to 1.006, p = 0.027). In conclusion, field triage of patient with STEMI decreased revascularization times, which preserved LV function, and improved early survival. (C) 2009 Published by Elsevier Inc. (Am J Cardiol 2009;103:907-912)

Aims: Historically, ST segment resolution (STR) assessed at ninety minutes post initiation of thrombolysis is a predictor of reperfusion success and cardiovascular outcomes in ST segment elevation myocardial infarction (STEMI). Our aim was to assess whether STR measured immediately post primary percutaneous intervention was (PPCI) was a useful predictor of adverse cardiovascular events.

This study sought to determine the prevalence as well as clinical and electrocardiographic correlates of patients referred for primary percutaneous coronary intervention (PCI) who had angiographically normal coronary arteries. Data for 690 consecutive patients with ST-elevation myocardial infarction (STEMI) referred for primary PCI within a metropolitan area health service were reviewed. Characteristics of patients with angiographically normal coronary arteries (n = 87; 13%) were compared with patients with angiographically shown culprit lesions (control group; n = 594). Nine patients with significant coronary disease, but no identifiable culprit lesion, were excluded. Electrocardiograms (ECGs) from both groups were reviewed by 2 cardiologists blinded to angiographic findings. Patients in the normal coronaries group were younger and had fewer risk factors. On expert review of ECGs, 55% of patients in the normal coronaries group had ST-elevation criteria for STEMI (vs 93% in the control group; p <0.001), but the ECG was considered consistent with a diagnosis of STEMI by both observers in only 33% (vs 92% in the control group; p <0.001). Left branch bundle block independently correlated with normal coronary arteries on multivariate analysis (odds ratio for STEMI 0.016, 95% confidence interval 0.004 to 0.064, p <0.001). The discharge diagnosis in the normal coronaries group was predominantly pericarditis (n = 72; 83%). In conclusion, the prevalence of angiographically normal coronary arteries in patients referred for primary PCI was 13%. Electrocardiographic correlation suggested that this can be reduced by adherence to conventional electrocardiographic criteria for STEMI diagnosis and review of ECGs by experienced clinicians.

Introduction: We sought to examine the outcomes of primary percutaneous coronary interventions (PPCI) for acute ST elevation myocardial infarction (STEMI) in patients aged ≥75 years in a contemporary Australian population.

Background Percutaneous treatment of stenoses involving aorto-ostial lesions is technically demanding and has been associated with lower procedural success and poorer clinical and angiographic outcomes when compared with non-ostial lesions. This study evaluated the immediate and long-term (2-year) outcome of aorto-ostial stenoses treated with paclitaxel-eluting stents (PES). Methods From February 2003 to December 2004, a total of 76 consecutive patients with 76 lesions underwent percutaneous intervention with PES for aorto-ostial lesions (right coronary artery, 37; left main, 26; saphenous vein graft, 13). All patients were clinically followed for the occurrence of major adverse cardiac events (MACE), defined as cardiac death, non-fatal myocardial infarction (MI), target lesion revascularization (TLR) or target vessel revascularization (TVR). Results All stents (1.7/lesion) were successfully deployed. Three lesions (3.9%) were pre-treated with debulking devices. Thirty-seven lesions (48.7%) were post-dilated with non-compliant balloons (balloon/artery ratio, 1.2). Stents were positioned protruding into the aortic lumen in 29 lesions (38.2%). Cumulative 2-year event-free survival was 68.4%. There was one angiographically-proven stent thrombosis occurring 427 days after TLR for restenosis after the index procedure. The restenosis rate at 7 months (median) was 20.0% and in-stent late lumen loss was 0.48 mm in 40 patients with angiographic follow-up. Conclusions Utilization of PES in this complex lesion subset is feasible and associated with favorable angiographic results at 7 months. However, the gradual increase in later events up to 2 years suggests that aorto-ostial disease remains problematic even in the era of drug-eluting stents.

Common clinical dilemmas in percutaneous coronary interventions , Common clinical dilemmas in percutaneous coronary interventions , کتابخانه مرکزی دانشگاه علوم پزشکی تهران